@jsc-bacterio.bsky.social
Reposted
Now available the new recommendations from the European Conference on Infections in Leukaemia for empirical and targeted antimicrobial therapy in patients with febrile neutropenia and hematological malignancy or after hematopoietic cell transplantation: thelancet.com/journals/lan...
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Con...
Febrile neutropenia can lead to life-threatening infections in patients with haematological
malignancies or after hematopoietic cell transplantation. Infection management is
challenged by rising antib...
thelancet.com
December 3, 2025 at 10:40 AM
Now available the new recommendations from the European Conference on Infections in Leukaemia for empirical and targeted antimicrobial therapy in patients with febrile neutropenia and hematological malignancy or after hematopoietic cell transplantation: thelancet.com/journals/lan...
Reposted
CMV Global "Update en Citomegalovirus: Diagnóstico y tratamiento" (Sesión 1)
📅28th October, 2025
📍Online
📚📝Programme/registration👇 update-citomegalovirus-cmvglobal.com
📅28th October, 2025
📍Online
📚📝Programme/registration👇 update-citomegalovirus-cmvglobal.com
update-citomegalovirus-cmvglobal.com – Update en Citomegalovirus: diagnóstico y tratamiento
update-citomegalovirus-cmvglobal.com
October 16, 2025 at 8:01 AM
CMV Global "Update en Citomegalovirus: Diagnóstico y tratamiento" (Sesión 1)
📅28th October, 2025
📍Online
📚📝Programme/registration👇 update-citomegalovirus-cmvglobal.com
📅28th October, 2025
📍Online
📚📝Programme/registration👇 update-citomegalovirus-cmvglobal.com
Reposted
New systematic review on the epidemiology of resistant bacterial infections in patients with hematological malignancies or HSCT recipients by the European Conference on Infections in Leukemia (ECIL)
www.journalofinfection.com/article/S016...
www.journalofinfection.com/article/S016...
October 6, 2025 at 9:39 AM
New systematic review on the epidemiology of resistant bacterial infections in patients with hematological malignancies or HSCT recipients by the European Conference on Infections in Leukemia (ECIL)
www.journalofinfection.com/article/S016...
www.journalofinfection.com/article/S016...
Reposted
📣 GESITRA-IC Meeting is coming! 📍 Madrid | 5–6 March 2026 🗓️ Save the date!
October 3, 2025 at 9:59 AM
📣 GESITRA-IC Meeting is coming! 📍 Madrid | 5–6 March 2026 🗓️ Save the date!
Reposted
The presentations from the 4th GESITRA-IC Scientific Meeting, held in Barcelona last June, are now available on the group's website.
seimc.org/grupos-de-es...
seimc.org/grupos-de-es...
August 11, 2025 at 12:39 PM
The presentations from the 4th GESITRA-IC Scientific Meeting, held in Barcelona last June, are now available on the group's website.
seimc.org/grupos-de-es...
seimc.org/grupos-de-es...
Reposted
Hurry up, registration is free and capacity is limited!!!
August 1, 2025 at 8:27 AM
Hurry up, registration is free and capacity is limited!!!
Reposted
📝 Desde GESITRA-IC os invitamos a completar esta breve encuesta para actualizar los perfiles profesionales del grupo y orientar vuestra participación en futuras colaboraciones, proyectos y actividades.
📅 Hasta el 14 de agosto
👉 forms.gle/29cVVZnsT9A7uq…
¡Gracias por participar!
📅 Hasta el 14 de agosto
👉 forms.gle/29cVVZnsT9A7uq…
¡Gracias por participar!
https://forms.gle/29cVVZnsT9A7uq…
July 27, 2025 at 11:59 AM
📝 Desde GESITRA-IC os invitamos a completar esta breve encuesta para actualizar los perfiles profesionales del grupo y orientar vuestra participación en futuras colaboraciones, proyectos y actividades.
📅 Hasta el 14 de agosto
👉 forms.gle/29cVVZnsT9A7uq…
¡Gracias por participar!
📅 Hasta el 14 de agosto
👉 forms.gle/29cVVZnsT9A7uq…
¡Gracias por participar!
Reposted
This symposium will provide state-of-the-art discussion on hot topics in the field of transplant infectious diseases. Chaired by Shahid Husain and Deepali Kumar
events.myconferencesuite.com/Transplant_I...
events.myconferencesuite.com/Transplant_I...
July 10, 2025 at 4:28 PM
This symposium will provide state-of-the-art discussion on hot topics in the field of transplant infectious diseases. Chaired by Shahid Husain and Deepali Kumar
events.myconferencesuite.com/Transplant_I...
events.myconferencesuite.com/Transplant_I...
Reposted
Great review and meta-analysis identifying areas of research on antimicrobial stewardship in SOTr that require the highest priority @ibis-investigacion.bsky.social @isciiisalud.bsky.social
July 9, 2025 at 4:58 PM
Great review and meta-analysis identifying areas of research on antimicrobial stewardship in SOTr that require the highest priority @ibis-investigacion.bsky.social @isciiisalud.bsky.social
Reposted
Effectiveness and safety of strategies to optimise antimicrobial use in solid organ transplant recipients. Systematic review and meta-analyses - eClinicalMedicine www.thelancet.com/journals/ecl...
Effectiveness and safety of strategies to optimise antimicrobial use in solid organ transplant recipients. Systematic review and meta-analyses
Strategies to optimise antimicrobial use are safe, with no negative impact on mortality
or transplant-related complications, and appear to improve some clinical outcomes
in SOTr, particularly when usi...
www.thelancet.com
July 9, 2025 at 4:58 PM
Effectiveness and safety of strategies to optimise antimicrobial use in solid organ transplant recipients. Systematic review and meta-analyses - eClinicalMedicine www.thelancet.com/journals/ecl...
Reposted
🚨 #Antifungal #prophylaxis in #SOT patients is evolving—but not uniformly.
A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers.
👇👇
link.springer.com/article/10.1...
A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers.
👇👇
link.springer.com/article/10.1...
Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC - Infection
Introduction Invasive fungal diseases (IFD) present serious risks to solid organ transplant recipients, particularly in the first 180 days post-transplant. Existing European and US guidelines offer li...
link.springer.com
July 4, 2025 at 3:11 PM
🚨 #Antifungal #prophylaxis in #SOT patients is evolving—but not uniformly.
A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers.
👇👇
link.springer.com/article/10.1...
A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers.
👇👇
link.springer.com/article/10.1...
Reposted
Pneumocystis jirovecii pneumonia in immunocompromised patients.
Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia url: academic.oup.com/ofid/article...
Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia url: academic.oup.com/ofid/article...
An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia
Pneumocystis jirovecii pneumonia is increasingly diagnosed in non-HIV immunocompromised patients. In this multicenter cohort, we observed rising diagnoses,
academic.oup.com
July 9, 2025 at 4:22 PM
Pneumocystis jirovecii pneumonia in immunocompromised patients.
Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia url: academic.oup.com/ofid/article...
Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia url: academic.oup.com/ofid/article...
Reposted
No differences in results when evaluating subgroups with a particularly high risk of recurrent infection, such as immunocompromised individuals.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection
This randomized clinical trial examines whether prophylactic oral vancomycin vs placebo reduces recurrent Clostridioides difficile infection in adults receiving antibiotics for another indication.
jamanetwork.com
July 9, 2025 at 4:29 PM
No differences in results when evaluating subgroups with a particularly high risk of recurrent infection, such as immunocompromised individuals.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Reposted
People who are older or immunocompromised are at higher risk of severe disease and death. Since there are no therapies or human vaccines, prevention relies on personal protective measures, WNV surveillance, and mosquito control interventions.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
West Nile Virus: A Review
This narrative review summarizes the pathophysiology, epidemiology, diagnosis, treatment, and prevention of West Nile virus infection.
jamanetwork.com
July 9, 2025 at 4:36 PM
People who are older or immunocompromised are at higher risk of severe disease and death. Since there are no therapies or human vaccines, prevention relies on personal protective measures, WNV surveillance, and mosquito control interventions.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Reposted
Organ transplants between people with HIV, backed by solid international studies, have been given the green light in Spain. Upcoming protocols will mark the beginning of this practice, which promotes equality in healthcare.
@gesida-seimc.bsky.social @sanidad.gob.es
www.sanidad.gob.es
@gesida-seimc.bsky.social @sanidad.gob.es
www.sanidad.gob.es
Ministerio de Sanidad
Sitio Web del Ministerio de Sanidad
www.sanidad.gob.es
July 9, 2025 at 4:44 PM
Organ transplants between people with HIV, backed by solid international studies, have been given the green light in Spain. Upcoming protocols will mark the beginning of this practice, which promotes equality in healthcare.
@gesida-seimc.bsky.social @sanidad.gob.es
www.sanidad.gob.es
@gesida-seimc.bsky.social @sanidad.gob.es
www.sanidad.gob.es
Reposted
🔬El #CSIC es el mayor organismo científico de España, con 124 institutos. Sus equipos realizan investigación básica para ampliar las fronteras del conocimiento
🧵 En este hilo te contamos las noticias destacadas de esta #SemanaCSIC
➡️ http://bit.ly/4908GgY
🧵 En este hilo te contamos las noticias destacadas de esta #SemanaCSIC
➡️ http://bit.ly/4908GgY
May 2, 2025 at 1:30 PM
🔬El #CSIC es el mayor organismo científico de España, con 124 institutos. Sus equipos realizan investigación básica para ampliar las fronteras del conocimiento
🧵 En este hilo te contamos las noticias destacadas de esta #SemanaCSIC
➡️ http://bit.ly/4908GgY
🧵 En este hilo te contamos las noticias destacadas de esta #SemanaCSIC
➡️ http://bit.ly/4908GgY
Reposted
🦠Un estudio liderado por el @ibis-investigacion.bsky.social identifica una molécula antiviral de amplio espectro
🔬El trabajo muestra la eficacia y seguridad de esta molécula para combatir las infecciones causadas virus
👉 tiny.cc/zm3i001
🔬El trabajo muestra la eficacia y seguridad de esta molécula para combatir las infecciones causadas virus
👉 tiny.cc/zm3i001
April 29, 2025 at 9:41 AM
🦠Un estudio liderado por el @ibis-investigacion.bsky.social identifica una molécula antiviral de amplio espectro
🔬El trabajo muestra la eficacia y seguridad de esta molécula para combatir las infecciones causadas virus
👉 tiny.cc/zm3i001
🔬El trabajo muestra la eficacia y seguridad de esta molécula para combatir las infecciones causadas virus
👉 tiny.cc/zm3i001
Reposted
🚨 NEW PUBLICATION 🚨 "Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy"
@theottlab.bsky.social
@ucsfmedicine.bsky.social
@qbi-ucsf.bsky.social
@theottlab.bsky.social
@ucsfmedicine.bsky.social
@qbi-ucsf.bsky.social
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy
This study describes a class of potent, bioavailable SARS-CoV-2 MPro inhibitors having an unusual mechanism of inhibition.
www.science.org
April 24, 2025 at 3:02 PM
🚨 NEW PUBLICATION 🚨 "Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy"
@theottlab.bsky.social
@ucsfmedicine.bsky.social
@qbi-ucsf.bsky.social
@theottlab.bsky.social
@ucsfmedicine.bsky.social
@qbi-ucsf.bsky.social
Organoids in Dynamic Culture: Microfluidics and 3D Printing Technologies | ACS Biomaterials Science & Engineering pubs.acs.org/doi/10.1021/...
Organoids in Dynamic Culture: Microfluidics and 3D Printing Technologies
With the rapid advancement of biomaterials and tissue engineering technologies, organoid research and its applications have made significant strides. Organoids are increasingly utilized in pharmacolog...
pubs.acs.org
April 24, 2025 at 6:45 AM
Organoids in Dynamic Culture: Microfluidics and 3D Printing Technologies | ACS Biomaterials Science & Engineering pubs.acs.org/doi/10.1021/...